TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
After allegedly pressuring the Chinese government to act first and adopt sanctions against nearly 10 local entities who the US claims provided North Korea with materials used in its nuclear program, the US has decided to act. In an unprecedented step, the Treasury Department slapped financial sanctions on two Chinese nationals and a Chinese shipping company over Read More…
Exhausted and demoralized after repeated buyouts and cutbacks in the newsroom, it seems the downtrodden journalists at the New York Times have finally had enough: In a pair of letters delivered to executive editor Dean Baquet and managing editor Joseph Kahn, the News Guild of New York said the New York Times editorial staff will Read More…
Government funding cuts seem to be the one overarching plot line tying the Trump Administration narrative together. We’ve seen this in the fiscal budget cuts and now in the most recent reveal of the Senate healthcare bill that could leave 22 million people without health insurance. Throughout this narrative, the media has done an influential Read More…
In years past, the Clinton Foundation enjoyed significant donations from individuals and countries that sought to purchase influence in Washington. But now, the McCain Institute is their new darling, having received large sums from the likes of George Soros and Saudi Arabia. WASHINGTON, D.C.– With the Clinton Foundation standing at the heart of the many Read More…
While we’re inundated with partisan nonsense over health care and Obamacare, the bipartisan FDA Reauthorization Act already allows Big Pharma to continue fleecing Americans. The circus sideshow of health care politics is providing yet another smokescreen for the real agenda of the corporate 2-party dictatorship. Contrary to the “different visions for America” portrayed by MSM Read More…
With the rapidly rising cost of prescriptions and the long list of side effects of most drugs, it should come as no surprise that it is not exactly big pharma’s top priority to consider what is in the patient’s best interest. What you might not realize, though, is that the government plays a large role in helping big Read More…